Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shokunbi, M. T.
Right arrow Articles by Floyd, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shokunbi, M. T.
Right arrow Articles by Floyd, P.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIDOCAINE
Medline Plus Health Information
*Transient Ischemic Attack

Stroke, Vol 17, 962-966, Copyright © 1986 by American Heart Association


ARTICLES

An evaluation of the effect of lidocaine in experimental focal cerebral ischemia

MT Shokunbi, AW Gelb, SJ Peerless, M Mervart and P Floyd

In order to determine the effect of lidocaine in focal cerebral ischemia, the left middle cerebral artery was transorbitally occluded in twenty cats. Eleven received lidocaine hydrochloride intravenously. The infusion was begun half an hour prior to clip occlusion and the rate was adjusted to maintain an isoelectric EEG. Nine cats served as controls, receiving an equivalent volume of 5% dextrose 0.2% saline. Thirteen animals (7 lidocaine-treated and 6 control) were sacrificed after six hours of left middle cerebral artery occlusion without reperfusion. In the remaining seven cats, the vessel was occluded for four hours prior to sacrifice. Ischemic neuronal alteration was assessed by both histochemical (2'3'5' triphenyl-2H-tetrazolium hydrochloride reaction) and histological examination. With both durations of ischemia, there was no significant difference in the extent and severity of neuronal alterations between the lidocaine- treated and control groups of animals.